Role of the angiotensin type 1 receptor in modulating the carotid chemoreflex in an ovine model of renovascular hypertension

被引:2
|
作者
Sohn, Chris Sung-Eun [1 ]
Chang, Joshua Wen-Han [1 ]
George, Bindu [1 ]
Chen, Siyi [1 ]
Ramchandra, Rohit [1 ]
机构
[1] Univ Auckland, Dept Physiol, Auckland, New Zealand
关键词
carotid body; chemoreflex; carotid blood flow; renal blood flow; hypertension; losartan; Ang-II; AT(1) receptor; SYMPATHETIC-NERVE ACTIVITY; II RECEPTOR; CONVERTING ENZYME; GENE-EXPRESSION; AT(1) RECEPTOR; HEART-FAILURE; BLOOD-FLOW; ONE-KIDNEY; BODY; 2-KIDNEY;
D O I
10.1097/HJH.0000000000003173
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: The carotid body has been implicated as an important mediator and putative target for hypertension. Previous studies have indicated an important role for angiotensin II in mediating carotid body function via angiotensin type-1 receptors (AT(1)R); however, their role in modulating carotid body function during hypertension is unclear. Methods: Using a large preclinical ovine model of renovascular hypertension, we hypothesized that acute AT(1)R blockade would lower blood pressure and decrease carotid body-mediated increases in arterial pressure. Adult ewes underwent either unilateral renal artery clipping or sham surgery. Two weeks later, flow probes were placed around the contralateral renal and common carotid arteries. Results: In both hypertensive and sham animals, carotid body stimulation using potassium cyanide caused dose-dependent increases in mean arterial pressure but a reduction in renal vascular conductance. These responses were not different between groups. Infusion of angiotensin II led to an increase in arterial pressure and reduction in renal blood flow. The sensitivity of the renal vasculature to angiotensin II was significantly attenuated in hypertension compared with the sham animals. Systemic inhibition of the AT(1)R did not alter blood pressure in either group. Interestingly carotid body-evoked arterial pressure responses were attenuated by AT(1)R blockade in renovascular hypertension but not in shams. Conclusion: Taken together, our findings indicate a decrease in vascular reactivity of the non-clipped kidney to angiotensin II in hypertension. The CB-evoked increase in blood pressure in hypertension is mediated in part, by the AT(1)R. These findings indicate a differential role of the AT(1)R in the carotid body versus the renal vasculature.
引用
收藏
页码:1421 / 1430
页数:10
相关论文
共 50 条
  • [1] Role of the Carotid Body in an Ovine Model of Renovascular Hypertension
    Chang, Joshua Wen-Han
    Tromp, Tycho R.
    Joles, Jaap A.
    McBryde, Fiona D.
    Paton, Julian F. R.
    Ramchandra, Rohit
    HYPERTENSION, 2020, 76 (05) : 1451 - 1460
  • [2] Angiotensin II Subtype AT1 Receptor Regulation in the Swine Model of Renovascular Hypertension
    Seckin, E.
    Vranesic, M.
    Demehri, S.
    Xia, J.
    Matthews, W. B.
    Hong, K.
    Bluemke, D.
    Lerman, L.
    Szabo, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S94 - S94
  • [3] Intracranial baroreflex is attenuated in an ovine model of renovascular hypertension
    Sydney Vari
    Sarah-Jane Guild
    Bindu George
    Rohit Ramchandra
    Scientific Reports, 11
  • [4] Intracranial baroreflex is attenuated in an ovine model of renovascular hypertension
    Vari, Sydney
    Guild, Sarah-Jane
    George, Bindu
    Ramchandra, Rohit
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Dissociation of hypotensive and growth modulating effects of endothelin receptor type a (ETA) and angiotensin receptor type 1 (AT1) antagonism in angiotensin II dependent hypertension
    Gerbaulet, SP
    Bohlender, J
    Krämer, J
    Quensel, C
    Gross, MC
    Leonhardt, H
    Dietz, R
    CIRCULATION, 1999, 100 (18) : 607 - 607
  • [6] Abnormal renovascular parathyroid hormone-1 receptor in hypertension: Primary defect or secondary to angiotensin II type 1 receptor activation?
    Welsch, Sandra
    Schordan, Eric
    Coquard, Catherine
    Massfelder, Thierry
    Fiaschi-Taesch, Nathalie
    Helwig, Jean-Jacques
    Barthelmebs, Mariette
    ENDOCRINOLOGY, 2006, 147 (09) : 4384 - 4391
  • [7] REGRESSION OF RENAL FIBROSIS AND DAMAGE IN EXPERIMENTAL RENOVASCULAR HYPERTENSION USING AN ANGIOTENSIN TYPE-1 RECEPTOR ANTAGONIST
    SCHUDECK, R
    JALIL, JE
    VIO, C
    NALLI, A
    CESPEDES, C
    EBENSPERGER, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A332 - A332
  • [8] Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: Role of the angiotensin II type 1 receptor
    Marcus, Noah J.
    Li, Yu-Long
    Bird, Cynthia E.
    Schultz, Harold D.
    Morgan, Barbara J.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 171 (01) : 36 - 45
  • [9] The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension
    Thomas, GN
    Chan, P
    Tomlinson, B
    DRUGS & AGING, 2006, 23 (02) : 131 - 155
  • [10] The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension
    G. Neil Thomas
    Paul Chan
    Brian Tomlinson
    Drugs & Aging, 2006, 23 : 131 - 155